» Articles » PMID: 37239085

Animal Models for Heart Transplantation Focusing on the Pathological Conditions

Overview
Journal Biomedicines
Date 2023 May 27
PMID 37239085
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiac transplant recipients face many complications due to transplant rejection. Scientists must conduct animal experiments to study disease onset mechanisms and develop countermeasures. Therefore, many animal models have been developed for research topics including immunopathology of graft rejection, immunosuppressive therapies, anastomotic techniques, and graft preservation techniques. Small experimental animals include rodents, rabbits, and guinea pigs. They have a high metabolic rate, high reproductive rate, small size for easy handling, and low cost. Additionally, they have genetically modified strains for pathological mechanisms research; however, there is a lacuna, as these research results rarely translate directly to clinical applications. Large animals, including canines, pigs, and non-human primates, have anatomical structures and physiological states that are similar to those of humans; therefore, they are often used to validate the results obtained from small animal studies and directly speculate on the feasibility of applying these results in clinical practice. Before 2023, PubMed Central at the United States National Institute of Health's National Library of Medicine was used for literature searches on the animal models for heart transplantation focusing on the pathological conditions. Unpublished reports and abstracts from conferences were excluded from this review article. We discussed the applications of small- and large-animal models in heart transplantation-related studies. This review article aimed to provide researchers with a complete understanding of animal models for heart transplantation by focusing on the pathological conditions created by each model.

References
1.
Costello R, Kissenpfennig A, Martins P, McDaid J . Development of transplant immunosuppressive agents - considerations in the use of animal models. Expert Opin Drug Discov. 2018; 13(11):1041-1053. DOI: 10.1080/17460441.2018.1535589. View

2.
Mosser D, Edwards J . Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008; 8(12):958-69. PMC: 2724991. DOI: 10.1038/nri2448. View

3.
Valenzuela N, Hong L, Shen X, Gao F, Young S, Rozengurt E . Blockade of p-selectin is sufficient to reduce MHC I antibody-elicited monocyte recruitment in vitro and in vivo. Am J Transplant. 2013; 13(2):299-311. PMC: 3563267. DOI: 10.1111/ajt.12016. View

4.
Braza M, Conde P, Garcia M, Cortegano I, Brahmachary M, Pothula V . Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance. Am J Transplant. 2018; 18(5):1247-1255. PMC: 5910259. DOI: 10.1111/ajt.14645. View

5.
Burns A, Chong A . Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol. 2010; 186(1):214-21. PMC: 8351406. DOI: 10.4049/jimmunol.1001172. View